AU552409B2 - Antitumor enhancer - Google Patents

Antitumor enhancer

Info

Publication number
AU552409B2
AU552409B2 AU85007/82A AU8500782A AU552409B2 AU 552409 B2 AU552409 B2 AU 552409B2 AU 85007/82 A AU85007/82 A AU 85007/82A AU 8500782 A AU8500782 A AU 8500782A AU 552409 B2 AU552409 B2 AU 552409B2
Authority
AU
Australia
Prior art keywords
antitumor
enhancer
antitumor enhancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU85007/82A
Other languages
English (en)
Other versions
AU8500782A (en
Inventor
Shigekazu Nakatsugawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of AU8500782A publication Critical patent/AU8500782A/en
Application granted granted Critical
Publication of AU552409B2 publication Critical patent/AU552409B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU85007/82A 1981-06-18 1982-06-18 Antitumor enhancer Ceased AU552409B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56094676A JPS57209225A (en) 1981-06-18 1981-06-18 Antitumor activity intensifier
JP56-94676 1981-06-18

Publications (2)

Publication Number Publication Date
AU8500782A AU8500782A (en) 1982-12-23
AU552409B2 true AU552409B2 (en) 1986-05-29

Family

ID=14116819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85007/82A Ceased AU552409B2 (en) 1981-06-18 1982-06-18 Antitumor enhancer

Country Status (6)

Country Link
EP (1) EP0068268B1 (enExample)
JP (1) JPS57209225A (enExample)
AU (1) AU552409B2 (enExample)
CA (1) CA1164346A (enExample)
DE (1) DE3263372D1 (enExample)
IT (1) IT1157211B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679648A (en) * 1994-11-30 1997-10-21 The University Hospital Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
CN101574362B (zh) * 2009-06-03 2012-05-23 西南大学 N-烷酰基虫草素在制备治疗肿瘤疾病的药物中的应用
CN103254195B (zh) * 2013-03-26 2016-08-03 内蒙古医科大学 7-氨基-四氮唑[1,5-a]并嘧啶-5-醇（化合物II）及其合成路线
US9782398B2 (en) * 2014-02-07 2017-10-10 Neurocrine Biosciences, Inc. Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof
MA56137B1 (fr) 2015-10-30 2024-03-29 Neurocrine Biosciences Inc Sels de dihydrochlorure de valbénazine et leurs polymorphes
CA3009169A1 (en) 2015-12-23 2017-06-29 Neurocrine Biosciences, Inc. Synthetic methods for preparation of (s)-(2r,3r,11br)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)
MY203491A (en) 2017-01-27 2024-06-30 Neurocrine Biosciences Inc Methods for the administration of certain vmat2 inhibitors
PL3684333T3 (pl) 2017-09-21 2025-06-23 Neurocrine Biosciences, Inc. Formulacja walbenazyny o wysokiej dawce oraz kompozycje, sposoby i zestawy z nią związane
KR20250070134A (ko) 2017-10-10 2025-05-20 뉴로크린 바이오사이언시즈 인코퍼레이티드 특정 vmat2 억제제의 투여 방법
KR20250110361A (ko) 2017-10-10 2025-07-18 뉴로크린 바이오사이언시즈 인코퍼레이티드 특정 vmat2 억제제의 투여 방법
MX2021001017A (es) 2018-08-15 2021-04-19 Neurocrine Biosciences Inc Metodos para la administracion de ciertos inhibidores de transportador vesicular de monoamina de proteinas transportadoras-2 (vmat2).
US10940141B1 (en) 2019-08-23 2021-03-09 Neurocrine Biosciences, Inc. Methods for the administration of certain VMAT2 inhibitors
CN113563401A (zh) * 2021-07-14 2021-10-29 河南牧业经济学院 一种新型虫草素烷酰胺衍生物及其制备方法和应用

Also Published As

Publication number Publication date
IT1157211B (it) 1987-02-11
EP0068268B1 (en) 1985-05-02
EP0068268A1 (en) 1983-01-05
CA1164346A (en) 1984-03-27
IT8248651A0 (it) 1982-06-16
JPS637164B2 (enExample) 1988-02-15
AU8500782A (en) 1982-12-23
DE3263372D1 (en) 1985-06-05
JPS57209225A (en) 1982-12-22

Similar Documents

Publication Publication Date Title
AU559140B2 (en) Perhydrobicyclopyrtolyl-aminoacid derivatives
AU559727B2 (en) Cephalosphorin derivatives
AU553462B2 (en) Oxazolidinone-2 derivatives
AU555213B2 (en) N-substituted-amido-fluoresein derivatives
AU544877B2 (en) Dichloroquinoline derivatives
AU552896B2 (en) Alkanesulfonanilide derivatives
AU552409B2 (en) Antitumor enhancer
AU560003B2 (en) Acylquinoline derivatives
AU541200B2 (en) Cyclopentapiene derivatives
AU529966B2 (en) Washer-dehydrator
AU549479B2 (en) Azolyl-phenoxy derivatives
AU554428B2 (en) Benzisoxazol-3yl derivatives
AU7887681A (en) Trailer
AU537889B2 (en) Sleeper-tamper
AU7639881A (en) Combined harrow-plow
AU8444982A (en) 4-amino-benzylamine derivatives
AU544455B2 (en) Apovincaminol derivatives
AU554243B2 (en) Benzylazole derivatives
AU8284582A (en) Dioxazabicyclic derivatives
AU1101883A (en) Mousqueton
AU545745B2 (en) Apovincaminol derivatives
AU546848B2 (en) Imidezole derivatives
AU526579B2 (en) N-aminoalkylimidazolidines
JPS57179163A (en) Antitumor
AU527316B2 (en) Allophanylpiperazine derivatives